Other studies have suggested changes in cerebral cholesterol, oxysterols, and cholesterol hydroperoxides may be related to PD progression [28]–[30] and it has been established that mutations in the GBA gene, that encodes glucocerebrosidase, confer increased risk for PD [31], [32]. This evidence concerns the gene GBA1 and Parkinson disease.